Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Periodontol ; 72(9): 1287-90, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11577964

ABSTRACT

Plasma cell granulomas (pseudotumors) are rare benign, tumor-like proliferations composed chiefly of plasma cells that manifest primarily in the lungs, but may occur in various anatomic locations. We report this case of a 54-year-old male who presented with an unusual maxillary anterior gingival overgrowth treated by excisional biopsy. Histological examination revealed a dense inflammatory cell infiltrate containing mainly plasma cells. Immunohistochemistry for kappa and lambda light chains showed a polyclonal staining pattern confirming a diagnosis of plasma cell granuloma. Intraoral plasma cell granuloma is exceedingly rare, although case reports documenting such lesions have been reported. This case highlights the need to biopsy unusual lesions to rule out potential neoplasms.


Subject(s)
Gingival Diseases/pathology , Granuloma, Plasma Cell/pathology , Diagnosis, Differential , Gingival Neoplasms/diagnosis , Humans , Male , Middle Aged
2.
Ophthalmology ; 105(3): 459-66, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9499776

ABSTRACT

OBJECTIVE: This study aimed to report the long-term outcomes of patients treated with an antibiotic drug combination for Bartonella henselae neuroretinitis. DESIGN: The study design was a retrospective case series. PARTICIPANTS: Seven consecutive patients with neuroretinitis and cat scratch disease participated. INTERVENTIONS: Patients underwent medical and ophthalmic evaluations. Blood cultures were obtained, and B. henselae antibody titers were measured. Tuberculosis, Lyme, toxoplasmosis, syphilis, and sarcoidosis were excluded. Patients received oral doxycycline 100 mg and rifampin 300 mg twice daily for 4 to 6 weeks and were observed for an average of 16 months (range, 10-24 months). Formal electrophysiologic testing was performed in three patients after resolution of neuroretinitis. MAIN OUTCOME MEASURES: The changes in ocular inflammation and visual function associated with treatment were recorded. Follow-up examinations and electrophysiologic testing documented sequelae. RESULTS: Patients presented following cat exposure with fever, malaise, and blurred vision. Decreased visual acuity (ranging from 20/40 to counting fingers) frequently was associated with dyschromatopsia and afferent pupillary defects. Ophthalmoscopic analysis showed signs of neuroretinitis, including nerve fiber layer hemorrhages, cotton-wool spots, multiple discrete lesions in the deep retina, and stellate macular exudates. B. henselae infection was confirmed with positive blood cultures or elevated immunofluorescent antibody titers or both. Therapy appeared to promote resolution of neuroretinitis, restoration of visual acuity, and clearance of bacteremia. After 1 to 2 years, two eyes had residual disc pallor, afferent pupillary defects, retinal pigmentary changes, and mildly decreased visual acuity. Electrophysiologic studies showed that when compared to the fellow eye, affected eyes had subnormal contrast sensitivity, abnormal color vision, and abnormal visually evoked potentials. Conversely, electroretinograms were normal in all subjects. CONCLUSIONS: B. henselae is a cause of neuroretinitis in cat scratch disease. Compared to historic cases, doxycycline and rifampin appeared to shorten the course of disease and hasten visual recovery. Long-term prognosis is good, but some individuals may acquire a mild postinfectious optic neuropathy.


Subject(s)
Bartonella henselae/isolation & purification , Cat-Scratch Disease/diagnosis , Drug Therapy, Combination/therapeutic use , Eye Infections, Bacterial/diagnosis , Optic Neuritis/diagnosis , Retinitis/diagnosis , Adult , Antibodies, Bacterial/analysis , Bartonella henselae/immunology , Cat-Scratch Disease/complications , Cat-Scratch Disease/drug therapy , Color Perception , Contrast Sensitivity , Doxycycline/therapeutic use , Electroretinography , Evoked Potentials, Visual , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/microbiology , Female , Fluorescein Angiography , Fundus Oculi , Humans , Male , Optic Neuritis/drug therapy , Optic Neuritis/microbiology , Retinitis/drug therapy , Retinitis/microbiology , Retrospective Studies , Rifampin/therapeutic use , Visual Acuity
3.
Ophthalmology ; 99(6): 920-5, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1630782

ABSTRACT

BACKGROUND: Toxoplasmosis is a leading cause of retinochoroiditis. Conventional multidrug therapy using sulfadiazine, pyrimethamine, and folinic acid is increasingly difficult to procure and administer safely. METHODS: To evaluate the efficacy of trimethoprim-sulfamethoxazole, a fixed-combination antibiotic, patients with active toxoplasmosis were treated with trimethoprim-sulfamethoxazole (Bactrim DS) with or without adjunctive clindamycin and prednisone for 4 to 6 weeks. RESULTS: All patients in this study (n = 16) had resolution of active retinochoroiditis and had improved vision, with an average gain of 5.2 lines of vision. Two patients developed a drug allergy. CONCLUSION: Trimethoprim-sulfamethoxazole appears to be a safe and effective substitute for sulfadiazine, pyrimethamine, and folinic acid (Leucovorin) in treating ocular toxoplasmosis.


Subject(s)
Toxoplasmosis, Ocular/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Adolescent , Adult , Aged , Child , Chorioretinitis/drug therapy , Chorioretinitis/parasitology , Clindamycin/therapeutic use , Drug Tolerance , Female , Fundus Oculi , Humans , Male , Middle Aged , Prednisone/therapeutic use , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...